Protagonist Therapeutics, Inc (NASDAQ:PTGX) has 303 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 9,715,999 | 311,767 | 3.32% | $848,595,367.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 6,144,006 | -6,248,006 | -50.42% | $536,617,484.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 5,413,690 | 1,156,461 | 27.16% | $472,831,684.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 5,059,053 | -697,224 | -12.11% | $441,857,689.00 |
| Johnson & Johnson | 31 Dec, 2025 | 4,898,366 | 0 | 0.00% | $427,823,286.00 |
| State Street Corp | 31 Dec, 2025 | 3,199,729 | 33,934 | 1.07% | $279,464,331.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 3,171,423 | 1,262,977 | 66.18% | $276,992,086.00 |
| UBS Group AG | 31 Dec, 2025 | 2,770,021 | 874,013 | 46.10% | $241,933,634.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 2,649,981 | 1,549,160 | 140.73% | $231,354,837.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 2,098,336 | 1,109,154 | 112.13% | $183,268,666.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 1,922,298 | 1,140,587 | 145.91% | $167,893,508.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,567,840 | 564,134 | 56.21% | $136,935,146.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,452,928 | 36,282 | 2.56% | $126,919,578.00 |
| Woodline Partners LP | 31 Dec, 2025 | 1,408,772 | -29,475 | -2.05% | $123,042,146.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 1,350,425 | 320,291 | 31.09% | $117,946,120.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,126,687 | 888,806 | 373.63% | $98,404,842.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,099,170 | -40,684 | -3.57% | $96,001,508.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,024,925 | -60,639 | -5.59% | $89,516,950.00 |
| Morgan Stanley | 31 Dec, 2025 | 879,024 | 110,665 | 14.40% | $76,774,142.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 867,580 | -792,174 | -47.73% | $75,774,437.00 |